Goldman Sachs Group Inc Procept Bio Robotics Corp Transaction History
Goldman Sachs Group Inc
- $605 Billion
- Q3 2024
A detailed history of Goldman Sachs Group Inc transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Goldman Sachs Group Inc holds 354,935 shares of PRCT stock, worth $28.7 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
354,935
Previous 279,963
26.78%
Holding current value
$28.7 Million
Previous $17.1 Million
66.26%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding PRCT
# of Institutions
266Shares Held
38MCall Options Held
262KPut Options Held
257K-
Vanguard Group Inc Valley Forge, PA4.84MShares$392 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$282 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.53MShares$124 Million0.04% of portfolio
-
Loomis Sayles & CO L P1.24MShares$101 Million0.13% of portfolio
-
State Street Corp Boston, MA1.18MShares$95.5 Million0.0% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $3.61B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...